Expected Market Growth of the Autoimmune Disease Diagnostics Market

Sep 6,2022 | Healthcare Services

An autoimmune disease is an illness in which the immune system erroneously attacks the body. The immune system can determine the difference between foreign cells and body cells. In an autoimmune disease, part of your body, including your joints or skin, is mistaken as alien by the immune system. It releases proteins referred to as autoantibodies which attack healthy cells. The disease can be divided into 2 general groups: Organ specific, where the autoantibodies attack a specific organ and Non-organ specific or systemic, where the autoantibodies attack multiple organ systems.

The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases such as rheumatoid arthritis, Hashimoto’s thyroiditis and presence of favourable government regulations will render significant impact on the autoimmune disease diagnostics market growth.

The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. This industry is experiencing substantial growth due to the high incidence of autoimmune diseases, increased awareness about autoimmune diseases, and growth in autoimmune disease research. There are almost 80 types of autoimmune diseases prevailing worldwide of which multiple sclerosis, type 1 diabetes, and rheumatoid arthritis are fairly common.

With the COVID–19 outbreak becoming a global stress test, manufacturers in the autoimmune disease diagnostics market started focusing on developing novel technologies for maximum testing within a minimum period. Thus, we expect that the physicians will see an increase in influx of patients, hence driving the autoimmune diseases diagnostics market growth. North America dominates the global market and is expected to maintain its position throughout the forecast period, followed by Europe and Asia Pacific.

On the basis of disease -

Key Company Profiles include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics,  bioMerieux SA, EUROIMMUN AG, Bio-Rad Laboratories and Quest Diagnostics.

A detailed analysis on the autoimmune diseases diagnostics market consisting of the company overview, business strategy, key product offerings, financial performance, key performance indicators, risk analysis, recent development, regional presence and swot analysis, can be found on Bharatbok under their Life Sciences – Healthcare Services category.

For more information, please visit Global Autoimmune Disease Diagnostics Market